- 主辦 / 主持人
- 台灣肺癌學會
- 積分
- B類 2 分
- 分類
- 未分類
- 聯絡人
- 高鶴容 02-28289897
- 活動日期
- 2025-11-30 (日) 09:00 ~ 11:30
- 地點
- 台北W Hotel
- 說明
Alex Forum 2025 – Meeting Summary (Nov. 29–30, Taipei)
The two-day Alex Forum gathered Taiwan’s leading lung-cancer specialists to discuss the evolving treatment landscape of ALK-positive and other NSCLC subtypes.
Day 1 focused on advances in ALK+ NSCLC therapy, from optimizing overall survival and post-surgical management with insights from the ALINA study, to tackling resistance mechanisms and exploring immunotherapy combinations in stage III and SCLC settings. Presentations emphasized long-term outcomes and strategies to overcome clinical challenges.
Alex Forum 2025 – Meeting Summary (Nov. 29–30, Taipei)
The two-day Alex Forum gathered Taiwan’s leading lung-cancer specialists to discuss the evolving treatment landscape of ALK-positive and other NSCLC subtypes.
Day 2 highlighted perioperative applications of TKIs, the role of immune checkpoint inhibitors in NSCLC, and managing cardiovascular, CNS, and metabolic adverse events to maintain patient quality of life. The forum concluded with perspectives on future innovations in lung-cancer surgery and novel therapeutic approaches, fostering collaboration among oncologists and thoracic physicians toward improving patient outcomes.
| 時間 | 主題 | |
|---|---|---|
| 沒有資料 | ||